Head and Neck Cancer Clinical Trials

A listing of Head and Neck Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Mirati Research Site
Birmingham Alabama 35294

A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies

View More ▼

Birmingham Alabama 35294

A Phase 1/1b clinical study for patients with Advanced Cancer

Arizona

View More ▼

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating Ferumoxytol followed by MM-398

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

Tucson Arizona 85719

A clinical research study of CPI-444 and CPI-444 + atezolizumab

California

Mirati Research Site
La Jolla California 92037

A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies

Mirati Research Site
Orange California 92868

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

Mirati Research Site
San Diego California 92093

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

Mirati Research Site
San Francisco California 94115

A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies

View More ▼

Los Angeles California 90033

A clinical study for patients with Cystic Fibrosis

Los Angeles California 90095

A clinical trial to evaluate treatments using MGA271 for patients

Los Angeles California 90033

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Los Angeles California 90033

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Los Angeles California 90033

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Los Angeles California 90033

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Los Angeles California 90033

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Los Angeles California 90025

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Los Angeles California 90095

Patients are needed to participate in a clinical research study evaluating MGA271 plus Ipilimumab for the treatment of Melanoma, Head and Neck Cancer or Non Small Cell Lung Cancer

San Diego California 92093

A Phase 1/1b clinical study for patients with Advanced Cancer

San Francisco California 94143

A clinical research study of CPI-444 and CPI-444 + atezolizumab

San Francisco California 94115

A Phase 2 clinical study for patients with Locally Advanced Basal Cell Carcinoma, Skin Cancer or Cutaneous Malignancy

San Francisco California 94115

Patients are needed to participate in a clinical research study evaluating Ferumoxytol followed by MM-398

San Francisco California 94550

Patients are needed to participate in a clinical research study of Combination of Varlilumab and Atezolizumab, Advanced Cancer

San Francisco California 94115

Patients are needed to participate in a clinical research study of Sentinella Intraoperative imaging protocol to evaluate Melanoma, Head and Neck Cancer or Breast Cancer

Santa Monica California 90404

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Colorado

Aurora Colorado 80045

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Denver Colorado

A clinical research study of MEDI4736 and INCB024360 for the treatment of Selected Advanced Solid Tumors

Connecticut

New Haven Connecticut

Patients are needed to participate in a clinical research study evaluating MGA271 plus Ipilimumab for the treatment of Melanoma, Head and Neck Cancer or Non Small Cell Lung Cancer

District of Columbia

Washington District of Columbia 20007

A clinical research study of Nilotinib + Cetuximab for the treatment of Colorectal Cancer or Head and Neck Cancer

Florida

Holy Cross Hospital
Fort Lauderdale Florida 33308

A Phase II, Multi-Center, Single-Arm, Global Study of MEDI4736 Monotherapy in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)

View More ▼

Gainesville Florida 32610

Patients are needed to participate in a clinical research study evaluating IZN-6N4 for the treatment of Oral Mucositis

Miami Florida

A clinical research study of MEDI4736 and INCB024360 for the treatment of Selected Advanced Solid Tumors

Miami Florida

A clinical trial seeking patients for a research study for the treatment of Cervical Cancer, Cancer or Head and Neck Cancer

Miami Florida 33136

Patients are needed to participate in a clinical research study evaluating IZN-6N4 for the treatment of Oral Mucositis

Sarasota Florida

A clinical research study of MEDI4736 and INCB024360 for the treatment of Selected Advanced Solid Tumors

Tampa Florida

A clinical research study of MEDI4736 and INCB024360 for the treatment of Selected Advanced Solid Tumors

Tampa Florida 33612

A clinical trial to evaluate treatments using MGA271 for patients

Tampa Florida 33607

Patients are needed to participate in a clinical research study evaluating Ferumoxytol followed by MM-398

Georgia

Memorial University Medical Center
Savannah Georgia 31404

ECOG E1305: A Phase III Randomized Trial of Chemotherapy with or without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer.

Memorial University Medical Center
Savannah Georgia 31404

RTOG 0920: A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer.

Memorial University Medical Center
Savannah Georgia 31404

RTOG 1016: Phase III Trial of Radiotherapy Plus Cetuximab Versus Chemoradiotherapy in HPV-Associated Oropharynx Cancer

Memorial University Medical Center
Savannah Georgia 31404

RTOG 1216: Randomized Phase II/III Trial of Surgery and Postoperative Radiation Delivered With Concurrent Cisplatin Versus Docetaxel Versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck

View More ▼

Atlanta Georgia 30322

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Illinois

Mirati Research Site
Chicago Illinois 60637

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

Mirati Research Site
Durate Illinois 91010

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

View More ▼

Chicago Illinois 60637

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Chicago Illinois 60637

A clinical trial to evaluate treatments using MGA271 for patients

Indiana

Indianapolis Indiana 46202

A clinical research study of CPI-444 and CPI-444 + atezolizumab